Cancer News
AI-informed context on recent cancer research and oncology news

Rutgers Cancer Institute and RWJBarnabas Health Showcase Innovative Cancer Research at ASCO 2026
June 7, 2026
Based on reporting from Newswise: Latest News
As the field of oncology continues to evolve, significant advancements are being made in cancer research. At the upcoming 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, researchers...
Read more →
Innovative Cancer Research to be Showcased at 2026 ASCO Annual Meeting
June 7, 2026
Based on reporting from Newswise: MedNews
As the American Society of Clinical Oncology (ASCO) Annual Meeting approaches, researchers from Rutgers Cancer Institute and RWJBarnabas Health are set to unveil groundbreaking findings that could...
Read more →
Innovative Cancer Research to be Showcased at 2026 ASCO Annual Meeting
June 7, 2026
Based on reporting from Newswise: Latest News
As the landscape of cancer treatment continues to evolve, researchers from Rutgers Cancer Institute and RWJBarnabas Health are set to present groundbreaking findings at the highly anticipated 2026...
Read more →
New Legislation Aims to Enhance Breast Cancer Screening Accessibility
June 7, 2026
Based on reporting from Newswise: Latest News
Recent developments in breast cancer legislation have sparked optimism among advocates and healthcare professionals. The U.S. House Energy and Commerce Committee has moved forward with two crucial...
Read more →
New Insights into Overcoming Resistance to KRAS Inhibitors in Colorectal Cancer
June 7, 2026
Based on reporting from Newswise: SciNews
Recent research from The University of Texas MD Anderson Cancer Center and Weill Cornell Medicine has shed light on the mechanisms behind resistance to KRAS inhibitors in colorectal cancer. This...
Read more →
Unraveling Resistance Mechanisms to KRAS Inhibitors in Colorectal Cancer
June 7, 2026
Based on reporting from Newswise: Latest News
Recent research from The University of Texas MD Anderson Cancer Center and Weill Cornell Medicine has shed light on the complex mechanisms that enable colorectal cancer cells to resist KRAS...
Read more →
New Clinical Trial Explores Focused Ultrasound as a Treatment for Pancreatic Cancer
June 7, 2026
Based on reporting from Newswise: MedNews
In a significant development for pancreatic cancer treatment, a clinical trial has commenced in the United States to evaluate the efficacy of focused ultrasound technology. The SUNRISE-II trial,...
Read more →
Mount Sinai Experts Advocate for Reform in Cancer Treatment Side-Effect Grading
June 7, 2026
Based on reporting from Newswise: MedNews
In a significant move aimed at enhancing the accuracy of cancer treatment evaluations, dermatologists and oncologists from the Icahn School of Medicine at Mount Sinai are calling for a comprehensive...
Read more →
Revolutionizing Diagnosis: The Promise of HAVCR1 Biomarker in Rare Cancers
June 7, 2026
Based on reporting from Newswise: MedNews
Recent advancements in cancer research have unveiled a significant breakthrough in the diagnosis and treatment of rare but aggressive forms of brain and eye cancers. A study published in the Clinical...
Read more →
Breakthrough Discovery of HAVCR1 Biomarker Enhances Early Detection of Rare Cancers
June 7, 2026
Based on reporting from Newswise: Latest News
Recent research has unveiled a significant advancement in the diagnosis of rare and aggressive forms of brain, spinal cord, and eye cancers, specifically through the identification of a new biomarker...
Read more →
Understanding the Role of Stress in Ovarian Cancer: New Insights into Immune Evasion
June 7, 2026
Based on reporting from Newswise: MedNews
Recent research from UT Southwestern Medical Center has unveiled critical insights into how stress can influence the progression of ovarian cancer. The study, published in the journal Endocrinology,...
Read more →
New Insights into Ovarian Cancer: Stress Hormones and Immune Evasion
June 7, 2026
Based on reporting from Newswise: Latest News
Recent research from UT Southwestern Medical Center has shed light on a critical mechanism through which ovarian cancer cells evade the immune system. This groundbreaking study reveals that the...
Read more →
Innovative Virus-Immunotherapy Strategy Shows Promise for High-Grade Neuroendocrine Tumors
June 7, 2026
Based on reporting from Newswise: MedNews
Researchers at the Sylvester Comprehensive Cancer Center are exploring an innovative approach to treating high-grade neuroendocrine tumors (NETs), a rare and aggressive form of cancer that has...
Read more →
Avatrombopag Shows Promise in Managing Chemotherapy-Induced Thrombocytopenia in GI Cancer Patients
June 7, 2026
Based on reporting from Newswise: MedNews
Recent findings presented at the 2026 American Society of Clinical Oncology (ASCO) annual meeting highlight a significant advancement in managing chemotherapy-induced thrombocytopenia (CIT) among...
Read more →
Innovative Virus-Immunotherapy Combination Offers Hope for Neuroendocrine Tumors
June 7, 2026
Based on reporting from Newswise: Latest News
In a promising development for cancer treatment, researchers at the Sylvester Comprehensive Cancer Center have initiated a phase I clinical trial that explores a novel combination of an oncolytic...
Read more →
Promising New Oral Drug Targets Chemotherapy-Induced Thrombocytopenia in GI Cancer Patients
June 7, 2026
Based on reporting from Newswise: Latest News
Recent findings presented at the ASCO 2026 Annual Meeting suggest a significant advancement in managing a common side effect of chemotherapy known as chemotherapy-induced thrombocytopenia (CIT). The...
Read more →
New Insights into Pancreatic Lesions Could Transform Cancer Detection and Prevention
June 7, 2026
Based on reporting from Newswise: MedNews
A groundbreaking study from the University of Michigan has unveiled critical insights into the transformation of precancerous pancreatic lesions into cancer, fundamentally altering existing paradigms...
Read more →
New Insights on Pancreatic Cancer Development: A Shift in Understanding Precancerous Lesions
June 7, 2026
Based on reporting from Newswise: Latest News
Recent research from the University of Michigan has unveiled a significant shift in our understanding of how precancerous lesions in the pancreas, known as pancreatic intraepithelial neoplasia...
Read more →
Exploring the Role of Gut Bacteria in Enhancing Immunotherapy for Melanoma
June 7, 2026
Based on reporting from Newswise: MedNews
Recent research from The George Washington University in collaboration with Weill Cornell Medicine has unveiled a significant link between gut bacteria and the effectiveness of immunotherapy in...
Read more →
Link Between Gut Bacteria and Immunotherapy Success: A New Frontier in Melanoma Treatment
June 7, 2026
Based on reporting from Newswise: Latest News
Recent research has unveiled a fascinating connection between gut bacteria and the effectiveness of immunotherapy in treating advanced melanoma, a particularly aggressive form of skin cancer....
Read more →